Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Up 83.8% in May

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 40,237 shares, a growth of 83.8% from the May 14th total of 21,893 shares. Based on an average trading volume of 4,758 shares, the days-to-cover ratio is presently 8.5 days.

Relief Therapeutics Stock Down 10.8%

OTCMKTS RLFTF traded down $0.04 on Monday, hitting $0.35. 3,005 shares of the company’s stock were exchanged, compared to its average volume of 3,300. The stock has a 50-day moving average of $0.45 and a 200-day moving average of $1.33. Relief Therapeutics has a 52 week low of $0.33 and a 52 week high of $4.88.

About Relief Therapeutics

Relief Therapeutics AG is a clinical?stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF?100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.